• Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune, India recognized by the Department of Industrial Policy & Promotion (DIPP). The company’s R&D center is located at NCL Innovation Park.
  • Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo.
  • The current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches.
  • In this socially-conscious endeavor, Ahammune has received support from the government in the form of tax-exemption for 3 years on capital gains.
  • We are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.